Stay updated on Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.

Latest updates to the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPublications section updated to indicate entries are automatically filled from PubMed and may not all reference the study. Revision: v3.3.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe government funding notice at the top of the page was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedNo significant changes detected between the two screenshots of the Study Details page for NCT03029598. The content and layout appear unchanged.SummaryDifference0.4%

- Check62 days agoChange DetectedUpgrade notice added about funding and operations; version updated to v3.2.0, replacing v3.1.0.SummaryDifference2%

- Check69 days agoChange DetectedRemoved detailed neoplasm and carcinoma terms and added a new revision tag: v3.1.0. This suggests a simplification or renaming of content with an updated version rather than adding substantive new material.SummaryDifference0.5%

- Check84 days agoChange DetectedAdded: Revision v3.0.2; Removed: Revision v3.0.1 and Back to Top. No changes to core content, pricing, or stock.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Carboplatin in Ovarian Cancer Clinical Trial page.